These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15625898)

  • 21. Evidence that umbilical cord blood contains a higher frequency of HLA class II-specific alloreactive T cells than adult peripheral blood. A limiting dilution analysis.
    Deacock SJ; Schwarer AP; Bridge J; Batchelor JR; Goldman JM; Lechler RI
    Transplantation; 1992 May; 53(5):1128-34. PubMed ID: 1374946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
    Leung AY; Kwok J; Lie AK; Chen P; Chen FE; Liang R
    Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the alloreactivity and anti-leukemia reactivity of cord blood mononuclear cells.
    Keever CA; Abu-Hajir M; Graf W; McFadden P; Prichard P; O'Brien J; Flomenberg N
    Bone Marrow Transplant; 1995 Mar; 15(3):407-19. PubMed ID: 7599566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
    Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limiting dilution analysis: quantification of IL-2 producing allospecific lymphocytes after renal and cardiac transplantation.
    Cattell EL; Cunningham AC; Bal W; Taylor RM; Dark JH; Kirby JA
    Transpl Immunol; 1994 Dec; 2(4):300-7. PubMed ID: 7704540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of alloreactive cytotoxic and lymphokine-secreting T lymphocytes in the development of acute graft-versus-host disease.
    Theobald M
    Transfus Sci; 1994 Sep; 15(3):189-96. PubMed ID: 10155540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings.
    Theobald M; Nierle T; Bunjes D; Arnold R; Heimpel H
    N Engl J Med; 1992 Dec; 327(23):1613-7. PubMed ID: 1435898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary human keratinocytes as targets in predicting acute graft-versus-host disease following HLA-identical bone marrow transplantation.
    van Dijk AM; Kessler FL; Verdonck LF; Stadhouders-Keet SA; van Lier RA; de Gast GC; Otten HG
    Br J Haematol; 2000 Dec; 111(3):791-6. PubMed ID: 11122139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helper T-lymphocyte precursor frequencies predict risks of graft-versus-host disease in bone marrow transplantation.
    Batchelor JR; Schwarer AP; Yin ZJ; Barrett AJ; Goldman JM; Lechler RI
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1237-8. PubMed ID: 8442100
    [No Abstract]   [Full Text] [Related]  

  • 30. Limiting dilution analysis of IL-2 producing cells: I. Studies of normal human peripheral blood.
    Moretti L; Giuliodori L; Stramigioli S; Luchetti F; Baldi A; Sparaventi G
    Haematologica; 1992; 77(6):463-9. PubMed ID: 1289183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of interleukin-15 on alloreactivity in umbilical cord blood.
    Lin SJ; Cheng PJ; Yan DC; Lee PT; Hsaio HS
    Transpl Immunol; 2006 Aug; 16(2):112-6. PubMed ID: 16860714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rapid limiting dilution assay for measuring frequencies of alloreactive, interleukin-2-producing T cells in humans.
    Deacock S; Schwarer A; Batchelor R; Goldman J; Lechler R
    J Immunol Methods; 1992 Feb; 147(1):83-92. PubMed ID: 1311737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bone marrow transplantation.
    Russell CA; Heilmann C; Madsen HO; Vindeløv LL
    Bone Marrow Transplant; 2001 May; 27(9):949-58. PubMed ID: 11436105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic responses of human umbilical cord blood.
    Risdon G; Gaddy J; Broxmeyer HE
    Blood Cells; 1994; 20(2-3):566-70; discussion 571-2. PubMed ID: 7749122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the alloreactive capacity of human umbilical cord blood: implications for graft-versus-host disease.
    Harris DT; LoCascio J; Besencon FJ
    Bone Marrow Transplant; 1994 Oct; 14(4):545-53. PubMed ID: 7858529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The helper T lymphocyte precursor (HTLp) frequency does not predict outcome after HLA-identical sibling donor G-CSF-mobilised peripheral blood stem cell transplantation.
    Healey G; Schwarer AP
    Bone Marrow Transplant; 2002 Sep; 30(6):341-6. PubMed ID: 12235517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclosphorine sensitivity in renal transplant patients. Quantitative assessment of interleukin-2-producing alloreactive helper T cells by limiting dilution analysis.
    Zanker B; Jooss J; Franz HE; Wagner H; Kabelitz D
    Transplantation; 1988 Aug; 46(2):313-6. PubMed ID: 2970136
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased induction of allogeneic-specific cord blood CD4+CD25+ regulatory T (Treg) cells: a comparative study of naïve and antigenic-specific cord blood Treg cells.
    Chang CC; Satwani P; Oberfield N; Vlad G; Simpson LL; Cairo MS
    Exp Hematol; 2005 Dec; 33(12):1508-20. PubMed ID: 16338494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of recipient-specific alloreactivity: is GVHD predictable?
    Theobald M; Bunjes D; Nierle T; Arnold R; Heimpel H
    Bone Marrow Transplant; 1993; 12 Suppl 3():S18-23. PubMed ID: 8124251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alloreactivity of umbilical cord blood mononuclear cells: specific hyporesponse to noninherited maternal antigens.
    Tsafrir A; Brautbar C; Nagler A; Elchalal U; Miller K; Bishara A
    Hum Immunol; 2000 Jun; 61(6):548-54. PubMed ID: 10825582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.